IntelliProve Company Profile

Background

Overview

IntelliProve, established in 2021 and headquartered in Ghent, Belgium, is a MedTech startup specializing in advanced health assessment solutions through facial analysis. The company's mission is to revolutionize health monitoring by providing fast, contactless, and equipment-free health assessments using standard smartphone cameras. By leveraging artificial intelligence and computer vision technologies, IntelliProve aims to enhance preventive healthcare and improve user engagement in digital health solutions.

Vision and Mission

IntelliProve envisions a future where health monitoring is seamlessly integrated into daily life, enabling individuals to proactively manage their well-being. The company's mission is to develop accessible, user-friendly, and inclusive solutions that lower barriers to preventive healthcare, thereby saving lives through improved health monitoring.

Industry Significance

In the rapidly evolving digital health landscape, IntelliProve's innovative approach addresses the growing demand for non-invasive, real-time health monitoring tools. By eliminating the need for specialized medical devices or wearables, IntelliProve's technology offers a scalable solution that can be integrated into various digital health platforms, corporate well-being programs, and health insurance services.

Key Strategic Focus

Core Objectives

Enhancing Preventive Healthcare: Developing tools that enable early detection and monitoring of health parameters to prevent the onset of diseases.

Improving User Engagement: Providing personalized health insights to increase user interaction and adherence to health programs.

Expanding Market Reach: Scaling operations to serve a broader European market and beyond.

Areas of Specialization

Facial Analysis for Health Assessment: Utilizing facial scanning technology to measure physiological and mental health biomarkers.

AI-Driven Health Monitoring: Employing artificial intelligence to analyze facial data and extract clinically validated health parameters.

Key Technologies Utilized

Remote Photoplethysmography (rPPG): A technique that detects variations in blood volume by analyzing light reflection from the skin, enabling the measurement of cardiovascular activity.

Machine Learning Algorithms: Advanced algorithms that process facial data to identify health biomarkers such as heart rate, respiratory rate, and heart rate variability.

Primary Markets Targeted

Digital Health Platforms: Integrating health assessment tools into existing digital health applications.

Corporate Well-being Programs: Providing employee well-being platforms with tools to monitor and improve health.

Health Insurance Services: Offering health insurers data-driven insights to enhance preventive care initiatives.

Financials and Funding

Funding History

November 2022: IntelliProve secured a €1 million seed investment led by Flanders Innovation and Entrepreneurship (VLAIO).

January 2025: The company raised an additional €1.25 million from Belgian VC/Venture Studio Miles Ahead and tech entrepreneurs, including Jeroen De Wit (Teamleader), Louis Jonckheere (Showpad, Wintercircus), Gilles Mattelin and Jorn Vanysacker (Henchman, Intuo), Matthias Geeroms (Lighthouse), and Joris Van Der Gucht (Silverfin). Existing investors such as The White and Yellow Cross (Wit-Gele Kruis) and imec.istart fund also participated in this round.

Utilization of Capital

The funds are intended to support IntelliProve's mission to enable health and well-being solutions by harnessing objective insights and enhancing preventive holistic health. This includes scaling operations, refining product offerings, and expanding market presence across Europe.

Pipeline Development

Product Offerings

Health Assessment Software: A plug-in tool designed to integrate seamlessly into existing digital platforms, enabling users to perform health assessments through facial scanning.

Development Stages

Product Validation: IntelliProve's technology has undergone rigorous validation, achieving CE-marking as a medical device and ISO27001 certification.

Market Expansion: As of 2024, the company operates in seven European countries, including Belgium, the Netherlands, the United Kingdom, Italy, France, Germany, and Denmark.

Target Conditions

The technology focuses on monitoring cardiovascular parameters such as heart rate and heart rate variability, as well as mental health indicators, facilitating early detection and management of related health conditions.

Anticipated Milestones

2025: Doubling team size to support scaling efforts and product refinement.

2028: Aiming to reach 10 billion health checks, representing millions of individuals benefiting from accessible and personalized healthcare.

Technological Platform and Innovation

Proprietary Technologies

Remote Photoplethysmography (rPPG): Utilizes smartphone cameras to detect subtle fluctuations in skin color resulting from facial blood flow, enabling the measurement of cardiovascular activity.

Significant Scientific Methods

Advanced Signal Processing: Transforms minuscule variations in facial blood flow into precise physiological signals.

Machine Learning Algorithms: Processes facial data to extract health biomarkers, ensuring accuracy and reliability.

AI-Driven Capabilities

Health Insights Generation: Combines face-scanned biomarker data with generative AI technology and large language models to offer human-interpretable explanations of users' well-being status.

Leadership Team

Joeri Tulkens, Ph.D. – Co-Founder, Chief Executive Officer, Medical Lead, and Board Member

Maxime Mattelin – Co-Founder, Chief Financial Officer, Head of Finance and Business, and Board Member

Brecht Dhuyvetters – Co-Founder, Chief Technology Officer, Head of Research and Development, and Board Member

Tanguy Sanglet – Co-Founder, Chief Scientific Officer, Head of Research and Development, and Board Member

Professional Backgrounds

The co-founders are long-time friends with deep expertise in startups and technology, united by a shared vision to reshape the healthcare landscape. Their combined experience spans technology development, healthcare, and business, positioning IntelliProve to lead the ongoing digital transformation of healthcare.

Leadership Changes

As of April 2025, there have been no significant changes or appointments within IntelliProve's leadership team.

Competitor Profile

Market Insights and Dynamics

The digital health market is experiencing rapid growth, driven by increasing demand for remote health monitoring solutions and preventive healthcare tools. The integration of AI and machine learning in health assessments is becoming a key differentiator among industry players.

Competitor Analysis

Vivify Health: Offers remote patient monitoring solutions, focusing on chronic disease management through connected devices and patient engagement tools.

Binah.ai: Provides AI-driven health and wellness monitoring solutions using video-based vital signs measurement, similar to IntelliProve's approach.

CardioDiagnostics: Specializes in cardiac monitoring technologies, offering wearable devices for continuous heart health assessment.

Docobo: Delivers digital health solutions for remote patient monitoring, emphasizing chronic disease management and telehealth services.

miDiagnostics: Develops diagnostic technologies for rapid and accurate health assessments, focusing on lab-on-chip solutions.

Competitive Landscape

IntelliProve differentiates itself by offering a contactless, equipment-free health assessment solution that integrates seamlessly into existing digital platforms. This approach addresses the growing demand for non-invasive, user-friendly health monitoring tools in the digital health market.

Strategic Collaborations and Partnerships

Significant Collaborations

The White and Yellow Cross (Wit-Gele Kruis): A partnership aimed at enhancing patient-centered home care through advanced health monitoring technologies.

imec.istart: Participation in this accelerator program has provided IntelliProve with funding, mentorship, and access to a broad network of partners and investors.

TAP: Integration of IntelliProve's health check into TAP's digital well-being platform to provide users with innovative tools for monitoring physical and mental health.

Impact on Market Position

These collaborations have strengthened IntelliProve's market position by expanding its reach, enhancing product offerings, and validating its technology through reputable partnerships.

Operational Insights

Strategic Considerations

Market Position: IntelliProve's unique technology positions it as a leader in contactless health assessment solutions within the digital health industry.

Competitive Advantages: The company's focus on user-friendly, non-invasive health monitoring tools provides a distinct competitive edge over traditional health assessment methods.

Differentiators: IntelliProve's ability to integrate its technology into various digital platforms without the need for additional hardware sets it apart from competitors relying on specialized devices.